📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Capricor

1.1 - Company Overview

Capricor Logo

Capricor

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.

Products and services

  • CAP-1002: Engineers an allogeneic, Phase 3 cell therapy for Duchenne muscular dystrophy using cardiosphere-derived cells that mediate immunomodulatory, anti-inflammatory, and anti-fibrotic effects
  • Exosome-based multivalent vaccine: Constructs an exosome-based vaccine under development with the NIH for SARS-CoV-2 prevention, utilizing Capricor's StealthX platform for targeted delivery
  • StealthX platform: Delivers a proprietary exosome technology enabling designer protein surface expression, cargo loading, and targeted delivery to architect precision therapeutics and vaccines

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Capricor

Cardialen Logo

Cardialen

HQ: United States Website
  • Description: Provider of pain-free cardioversion therapies for atrial fibrillation, developing implantable low-energy (low voltage) atrial cardioverters to address major unmet needs of this condition.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardialen company profile →
Rapidscan Pharma Logo

Rapidscan Pharma

HQ: United States Website
  • Description: Provider of regadenoson, a pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease, with licensed rights to sell in Europe and select territories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rapidscan Pharma company profile →
Crux Biomedical Logo

Crux Biomedical

HQ: United States Website
  • Description: Provider of biotech solutions addressing the clinical limitations of current vena cava filters.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crux Biomedical company profile →
AUM Cardiovascular Logo

AUM Cardiovascular

HQ: United States Website
  • Description: Provider of medical device manufacturing solutions specializing in the biotechnology, medical, and healthcare fields.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AUM Cardiovascular company profile →
Spectrum Dynamics Medical Logo

Spectrum Dynamics Medical

HQ: United States Website
  • Description: Provider of innovative high definition functional imaging technology that delivers high-speed, high-resolution nuclear images in compact systems designed to meet clinical and workflow demands, including BroadView™ Technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spectrum Dynamics Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Capricor

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Capricor

2.2 - Growth funds investing in similar companies to Capricor

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Capricor

4.2 - Public trading comparable groups for Capricor

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Capricor

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Capricor

What does Capricor do?

Capricor is a provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.

Who are Capricor's competitors?

Capricor's competitors and similar companies include Cardialen, Rapidscan Pharma, Crux Biomedical, AUM Cardiovascular, and Spectrum Dynamics Medical.

Where is Capricor headquartered?

Capricor is headquartered in United States.

How many employees does Capricor have?

Capricor has 1,000 employees 🔒.

When was Capricor founded?

Capricor was founded in 2010 🔒.

What sector and industry vertical is Capricor in?

Capricor is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Capricor

Who are the top strategic acquirers in Capricor's sector and industry

Top strategic M&A buyers and acquirers in Capricor's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Capricor?

Top strategic M&A buyers groups and sectors for Capricor include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Capricor's sector and industry vertical

Which are the top PE firms investing in Capricor's sector and industry vertical?

Top PE firms investing in Capricor's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Capricor's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Capricor's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Capricor's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Capricor include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Capricor's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Capricor?

The key public trading comparables and valuation benchmarks for Capricor include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Capricor for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Capricor with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Capricor's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Capricor with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Capricor's' sector and industry vertical?

Access recent funding rounds and capital raises in Capricor's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Capricor

Launch login modal Launch register modal